NeoGenomics Inc (FRA:NG9)
€ 12 0 (0%) Market Cap: 1.57 Bil Enterprise Value: 1.78 Bil PE Ratio: 0 PB Ratio: 1.82 GF Score: 70/100

Q2 2020 Neogenomics Inc Earnings Call Transcript

Jul 28, 2020 / 12:30PM GMT
Release Date Price: €31.4 (+2.61%)
Operator

Good day, ladies and gentlemen, and welcome to your NeoGenomics' Second Quarter 2020 Earnings Call. (Operator Instructions)

At this time, it is my pleasure to turn the floor over to your host, Doug VanOort. Sir, the floor is yours.

Douglas M. VanOort
NeoGenomics, Inc. - Chairman & CEO

Thank you, Karen, and good morning, everyone. I'd like to welcome everyone to NeoGenomics' Second Quarter 2020 Conference Call. Joining me from our Fort Myers headquarters, with social distancing precautions in place, are Kathryn McKenzie, our Chief Financial Officer; Rob Shovlin, President of our Clinical Division; and Bill Bonello, President of our Informatics Division and Director of Investor Relations. Joining the call via phone from locations across the country are George Cardoza, President of our Pharma Services Division; Dr. Larry Weiss, our Chief Medical Officer; and Doug Brown, our Chief Strategy and Corporate Development Officer.

Before we begin our prepared remarks, Bill Bonello will read the standard language about forward-looking statements.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot